Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | PLUR | PTN | ||
| Company | Catabasis Pharma | Pluri Inc | Palatin Technologies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 9.21 | 3.40 | 17.70 | ||
| High | 9.21 | 3.40 | 18.50 | ||
| Low | 8.46 | 3.35 | 17.20 | ||
| Latest | 8.54 | 3.35 | 17.20 | ||
| Change | -0.64 | -0.05 | -0.22 | ||
| % Change | -6.97% | -1.33% | -1.26% | ||
| Volume | 98,800 | 2,800 | 13,578 | ||
| 20-Day Average Volume | 395,311 | 6,290 | 14,600 | ||
| Previous Close | 9.18 | 3.39 | 17.42 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 3.27 | 21.19 | ||
| 20-Day Raw Stochastic | 56.46% | 51.52% | 2.41% | ||
| 20-Day Relative Strength | 43.24 | 50.03 | 41.85 | ||
| Weighted Alpha | -50.43 | -28.17 | -5.10 | ||
| Today's Opinion | 88% Sell | 72% Sell | 40% Buy | ||
| Previous Opinion | 72% Sell | 56% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +0.60% since 03/25/26 | -18.10% since 03/25/26 | ||
| Low | 8.46 on 09/08/21 | 3.20 on 03/27/26 | 17.02 on 03/31/26 | ||
| High | 10.26 on 09/02/21 | 3.40 on 04/01/26 | 21.41 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -6.94% since 02/27/26 | -17.70% since 02/27/26 | ||
| Low | 6.31 on 08/20/21 | 3.01 on 03/24/26 | 17.02 on 03/31/26 | ||
| High | 10.26 on 09/02/21 | 3.71 on 03/04/26 | 24.49 on 03/06/26 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | +12.04% since 12/31/25 | +11.83% since 12/31/25 | ||
| Low | 6.31 on 08/20/21 | 2.88 on 01/06/26 | 14.13 on 01/02/26 | ||
| High | 15.72 on 06/16/21 | 3.90 on 02/09/26 | 24.49 on 03/06/26 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -25.22% since 10/01/25 | +119.11% since 10/01/25 | ||
| Low | 6.31 on 08/20/21 | 2.82 on 12/17/25 | 5.61 on 10/27/25 | ||
| High | 22.01 on 03/18/21 | 4.86 on 11/13/25 | 31.00 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 34,123 | 30,872 | ||
| Shares Outstanding, K | 3,904 | 10,051 | 1,772 | ||
| Annual Sales | 0 | 1,340,000 | 0 | ||
| Annual Net Income | -37,300,000 | -22,580,000 | -17,310,000 | ||
| Last Quarter Sales | 0 | 200,000 | 120,000 | ||
| Last Quarter Net Income | -7,470,000 | -6,540,000 | -7,260,000 | ||
| 60-Month Beta | 1.66 | 0.66 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.71 on 02/12/26 | -2.86 on 02/17/26 | ||
| Latest Earnings Date | 11/11/21 | 05/12/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||